Viridian Therapeutics, Inc. (VRDN)
NASDAQ: VRDN · Real-Time Price · USD
13.50
-0.95 (-6.54%)
Mar 31, 2025, 3:51 PM EDT - Market open

Viridian Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Revenue
0.30.311.772.961.05
Upgrade
Revenue Growth (YoY)
-3.82%-82.28%-40.20%182.19%-76.46%
Upgrade
Cost of Revenue
238.25159.77100.8956.8928.3
Upgrade
Gross Profit
-237.95-159.45-99.12-53.92-27.25
Upgrade
Selling, General & Admin
61.089535.1825.8113.27
Upgrade
Operating Expenses
61.089535.1825.8113.27
Upgrade
Operating Income
-299.04-254.45-134.3-79.73-40.52
Upgrade
Interest Expense
-3.05-1.85-0.49-0-0.51
Upgrade
Interest & Investment Income
32.1318.564.920.320.17
Upgrade
EBT Excluding Unusual Items
-269.95-237.73-129.87-79.41-40.85
Upgrade
Pretax Income
-269.95-237.73-129.87-79.41-110.72
Upgrade
Net Income
-269.95-237.73-129.87-79.41-110.72
Upgrade
Preferred Dividends & Other Adjustments
-61.39-62.73-42.83--
Upgrade
Net Income to Common
-208.56-175.01-87.04-79.41-110.72
Upgrade
Shares Outstanding (Basic)
684532124
Upgrade
Shares Outstanding (Diluted)
684532124
Upgrade
Shares Change (YoY)
51.68%39.48%169.22%235.07%70.27%
Upgrade
EPS (Basic)
-3.07-3.91-2.71-6.66-31.13
Upgrade
EPS (Diluted)
-3.07-3.91-2.71-6.66-31.13
Upgrade
Free Cash Flow
-232.83-185.07-94.64-54.92-29.82
Upgrade
Free Cash Flow Per Share
-3.43-4.13-2.95-4.61-8.38
Upgrade
Operating Margin
-99018.21%-81035.03%-7579.23%-2690.79%-3858.95%
Upgrade
Profit Margin
-69059.60%-55734.71%-4912.13%-2680.15%-10544.29%
Upgrade
Free Cash Flow Margin
-77096.03%-58938.85%-5340.58%-1853.49%-2840.10%
Upgrade
EBITDA
-298.5-253.93-134.05-79.61-40.28
Upgrade
D&A For EBITDA
0.540.520.260.120.24
Upgrade
EBIT
-299.04-254.45-134.3-79.73-40.52
Upgrade
Revenue as Reported
----1.05
Upgrade
Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q